Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB | NEJM

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB | NEJM
COVID - cover
Magazine
Avatar - Nuno Ferreira

Nuno Ferreira flipped this story into COVID63d

Related storyboards